Monoclonal antibodies specific to endothelial cell cadherins...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/12 (2006.01) A01K 67/027 (2006.01) A61K 38/08 (2006.01) A61K 38/17 (2006.01) A61K 39/39 (2006.01) A61K 39/395 (2006.01) C07K 7/06 (2006.01) C07K 14/705 (2006.01) C07K 16/28 (2006.01) C07K 16/46 (2006.01) C12N 5/16 (2006.01) C12N 15/11 (2006.01) C12N 15/13 (2006.01) G01N 33/53 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2245956

A new VE-cadherin molecule is provided. Monoclonal antibodies that specifically bind to and neutralize an extracellular domain of a VE-cadherin molecule are provided. In vitro and in vivo methods of using these antibodies are also provided.

Nouvelle molécule de cadhérine endothéliale vasculaire (VE). On décrit des anticorps monoclonaux ayant une capacité spécifique de liaison et de neutralisation par rapport à un domaine extracellulaire d'une molécule de cadhérine de type VE. On décrit aussi des procédés in vitro et in vivo d'utilisation de ces anticorps.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Monoclonal antibodies specific to endothelial cell cadherins... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Monoclonal antibodies specific to endothelial cell cadherins..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibodies specific to endothelial cell cadherins... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1405091

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.